Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results
2023 · Nature Medicine · 511 citations
https://doi.org/10.1038/s41591-023-02528-9
H
Hisayuki Yokoyama
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
229
Papers
4.6K
Citations
27
h-index
61
i10-index
Hisayuki Yokoyama is an academic researcher from Tohoku University. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Immune Cell Function and Interaction & Hematopoietic Stem Cell Transplantation. The author has an h-index of 27, co-authored 195 publications.
ORCID: 0000-0001-7658-0687Papers by this author
worksExploring the mechanistic link between SF3B1 mutation and ring sideroblast formation in myelodysplastic syndrome
2022 · Scientific Reports · 20 citations
https://doi.org/10.1038/s41598-022-18921-2
Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial
2025 · The Lancet · 3 citations
https://doi.org/10.1016/s0140-6736(25)02360-8
Impact of graft-versus-host disease on outcomes of cord blood transplantation according to HLA disparity and its prophylaxis type
2025 · Annals of Hematology · 2 citations
https://doi.org/10.1007/s00277-025-06415-w
111: Lenalidomide Directly Upregulates NK (Natural Killer) Cell Trail and Granzyme B Expression: Implications for Adoptive NK Cell Immunotherapy following Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
2008 · Biology of Blood and Marrow Transplantation · 0 citations
https://doi.org/10.1016/j.bbmt.2007.12.120
P-096 Patient-Reported Outcomes in the Phase 3 CARTITUDE-4 Study of Ciltacabtagene Autoleucel Vs Standard of Care in Patients With Lenalidomide-Refractory Multiple Myeloma After 1–3 Lines of Therapy
2024 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(24)01999-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat